Doc.com Expands U.S. Rollout with Florida Launch, Advancing AI-Powered Blockchain Secured Healthcare Access

The AI and blockchain-powered telemedicine platform continues its national expansion, bringing secure, affordable care to patients across the state

NEW YORK–(BUSINESS WIRE)–Doc.com, the pioneering healthcare technology company redefining access to care through artificial intelligence and blockchain integration, today announced the launch of its telemedicine platform in Florida as part of its ongoing United States expansion. The Florida rollout marks a significant milestone in the company’s multi-phase national growth strategy.

Doc New Logo Color 2
Doc New Logo Color 2

Through a seamless mobile experience, Florida residents can now connect with licensed healthcare professionals within the state for secure, convenient telehealth consultations. The platform leverages AI-assisted tools designed to support clinical workflows and enhance provider decision-making, personalize care pathways, and optimize provider efficiency, while blockchain-based infrastructure designed to enhance transparency and data integrity, transparency, and patient control over medical records.

As part of its introductory experience, new users may access complimentary teleconsultation, available in eligible jurisdictions and subject to applicable regulations. These minutes may be used across one or multiple sessions as part of an initial trial. Subsequent consultations are available at standard rates.

Complimentary consultation time does not apply to emergency services and does not create a patient-provider relationship until formally established in accordance with applicable state laws.

“Florida represents a critical step in our U.S. expansion strategy,” said Charles Nader, CEO and Founder of Doc.com. “We are building a healthcare ecosystem where technology enhances human care, making it more accessible, more transparent, and more intelligent. Our AI-driven infrastructure supports providers while empowering patients with secure, affordable access to healthcare services.”

Doc.com’s broader U.S. rollout began with Phase 1 launches in West Virginia and continues through additional phases across 2026, subject to regulatory approvals and operational readiness, with nationwide availability targeted for early 2027. Florida’s activation strengthens the company’s footprint in high-demand markets and reinforces its commitment to scaling accessible care across diverse communities.

Beyond telemedicine, Doc.com is building a vertically integrated healthcare ecosystem that connects physical health, mental health, pharmacy services, veterinary care, and education within one unified platform. Its blockchain layer is designed to support secure medical record management, AI-enhanced diagnostics, and efficient healthcare transactions, creating a transparent and interoperable system.

For more information about Doc.com’s platform and expansion, visit www.doc.com.

About Doc.com

Doc.com is a healthcare technology company building the future of AI-driven healthcare solutions. The company accelerates the evolution of healthcare through a vertically integrated ecosystem that connects telemedicine, mental health support, veterinary care, pharmacy, and education in one seamless platform. Doc.com’s AI-powered technology enhances diagnostics, personalizes treatment, and enables medication delivery, while blockchain technology ensures transparency, security, and trust. With a mission to make access to care more equitable and sustainable, Doc.com is committed to advancing health as a human right by providing affordable, privacy-compliant, and technology-enabled healthcare solutions to communities worldwide.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our potential listing on a national securities exchange, our business strategy, plans and objectives, market opportunity, competitive position, future financial performance, and the assumptions underlying such statements.

These forward-looking statements are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties, and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements are generally identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would,” and similar expressions, although not all forward-looking statements contain these identifying words.

Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include, but are not limited to: risks related to our ability to complete our trading on Nasdaq, general economic conditions and market volatility; our ability to execute our business strategy; competitive pressures; regulatory developments; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent registration statement and periodic reports.

We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

Contacts

For more corporate information please visit: doc.com
For further information, please contact: Tiffany Cummins

Email: [email protected]
Business Tel: 925-212-4200

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.